Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS

Glutaredoxin 3 (GLRX3) is antioxidant enzyme, maintaining a low level of ROS, thus contributing to the survival and metastasis of several types of cancer. However, the expression and functions of GLRX3 have not been addressed in nasopharyngeal carcinoma (NPC). In this study, we found that GLRX3 was...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: He, Feng, Wei, Lili, Luo, Wenqi, Liao, Zhipeng, Li, Bo, Zhou, Xiaoying, Xiao, Xue, You, Jingping, Chen, Yufeng, Zheng, Shixing, Li, Ping, Murata, Mariko, Huang, Guangwu, Zhang, Zhe
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5095054/
https://ncbi.nlm.nih.gov/pubmed/27203742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9454
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky